+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Digital Therapeutics - Global Strategic Business Report

  • PDF Icon

    Report

  • 326 Pages
  • July 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4804793
The global market for Digital Therapeutics is estimated at US$5.7 Billion in 2023 and is projected to reach US$32.9 Billion by 2030, growing at a CAGR of 24.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the B2B sales channel segment, which is expected to reach US$30.9 Billion by 2030 with a CAGR of 25.3%. The B2C sales channel segment is also set to grow at 17.2% CAGR over the next 8 years.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $2.3 Billion in 2023, and China, forecasted to grow at an impressive 27.7% CAGR to reach $3.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Digital Therapeutics Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Digital Therapeutics Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Digital Therapeutics Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Aptar Digital Health, Better Therapeutics, Inc, Biofourmis Inc., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 136 Featured):

  • Aptar Digital Health
  • Better Therapeutics, Inc
  • Biofourmis Inc.
  • Canary Health, Inc.
  • Click Therapeutics, Inc.
  • Fitbit Health Solutions
  • Pear Therapeutics, Inc.
  • Wellthy Therapeutics Pvt Ltd

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Digital Therapeutics is Poised to Benefit from the Increasingly Robust Outlook for Digital Health
  • Digital Healthcare Sets the Stage for the Rise of Digital Therapeutics: Global Market for Digital Health (In US$ Billion) for Years 2023, 2025, and 2027
  • Global Economic Update
  • Competition
  • Digital Therapeutics - Global Key Competitors Percentage Market Share in 2023 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)
  • Digital Therapeutics: Overview & Market Outlook
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Growing Global Focus on Meeting Unmet Needs in Mental Healthcare to Benefit Growth of Digital Therapeutics
  • Shockingly High Burden of Mental Disorders & the Ensuing Focus to Meet Unmet Care Needs Primes Digital Therapeutics for Mass Adoption: Global Economic Cost of Mental Illnesses (In US$ Trillion) for Years 2023, 2025, 2027, 2029 & 2031
  • Artificial Intelligence to Play a Key Role in Improving the Effectiveness of Digital Therapeutics
  • High Prevalence of Chronic Diseases and Growing Focus Long-Term Management & Preventative Healthcare Widens Growth Opportunities
  • Rising Prevalence of Chronic Diseases Amplifies the Need for Addressing Management of These Diseases Through Digital Therapeutics: Global Cost of Chronic Diseases (In US$ Trillion) for the Years 2023, 2025, 2027, 2029 and 2031
  • Here’s How Digital Therapeutics Can Help Improve Clinical Outcomes Across the Cardiac Continuum
  • Global Annual Medical Cost of Cardiovascular Diseases in US$ Billion (2010-2030)
  • How Digital Therapeutics is Changing the Oncology Care Landscape?
  • Worrisome Epidemic Increase in Cancer Incidence to Help Accelerate Adoption of Digital Therapeutics: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Rise of mHealth & Smart Medical Devices & Wearables Paves the Way for More Spontaneous Adoption of Digital Therapeutics
  • Growing Familiarity with mHealth & Use of Medical Wearables Means There is One Less Obstacle in the Implementation of Digital Therapeutics: Global Market for mHealth & Medical Wearables (In US$ Billion) for Years 2023, 2025, 2027, 2029 and 20231
  • As Healthcare Costs Continue to Spiral, Growing Much Faster Than National GDP, Focus Shifts to Digital Therapeutics for its Ability to Lower Cost of Care
  • Growing Urgency to Rein-in Spiraling Healthcare Costs Leads Healthcare Community to Take a Closer Look at Digital Therapeutics: Healthcare Costs as a % of GDP by Country 2020 VS 2023
  • Growing Preference for Personalized Medicine Doubles the Focus on Digital Therapeutics
  • Robust Outlook for Personalized Medicine to Create a Parallel Opportunity for Digital Therapeutics: Global Market for Personalized Medicines (In US$ Billion) for Years 2023 2025, 2027, 2029 and 2031
  • Here’s How AR/VR Technologies are Changing the Future of Digital Therapeutics
  • The Many Benefits of 5G in Healthcare to Catalyze Adoption of Digital Therapeutics
  • Rapid Penetration of 5G Will Make Implementation of Digital Therapeutics Seamless & More Efficient to Use: Global 5G Subscription (In Million) for Years 2023, 2025, 2027 and 2029
  • Technology and Innovation to Continue to Drive Adoption of Digital Therapeutics
  • Cybersecurity Storms Into the Spotlight. Here’s Why
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Digital Therapeutics Market Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Digital Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 3: World 7-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for B2B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 5: World 7-Year Perspective for B2B by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 6: World Recent Past, Current & Future Analysis for B2C by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 7: World 7-Year Perspective for B2C by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Treatment / Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 9: World 7-Year Perspective for Treatment / Care by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Preventive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 11: World 7-Year Perspective for Preventive by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Digital Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 12: USA Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 13: USA 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • Table 14: USA Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 15: USA 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
CANADA
  • Table 16: Canada Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 17: Canada 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • Table 18: Canada Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 19: Canada 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
JAPAN
  • Table 20: Japan Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 21: Japan 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • Table 22: Japan Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 23: Japan 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
CHINA
  • Table 24: China Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 25: China 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • Table 26: China Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 27: China 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
EUROPE
  • Digital Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 28: Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 29: Europe 7-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • Table 30: Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 31: Europe 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • Table 32: Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 33: Europe 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
FRANCE
  • Table 34: France Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 35: France 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • Table 36: France Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 37: France 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
GERMANY
  • Table 38: Germany Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 39: Germany 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • Table 40: Germany Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 41: Germany 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
ITALY
  • Table 42: Italy Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 43: Italy 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • Table 44: Italy Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 45: Italy 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
UNITED KINGDOM
  • Table 46: UK Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 47: UK 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • Table 48: UK Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 49: UK 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
REST OF EUROPE
  • Table 50: Rest of Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 51: Rest of Europe 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • Table 52: Rest of Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 53: Rest of Europe 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
ASIA-PACIFIC
  • Digital Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 54: Asia-Pacific Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 55: Asia-Pacific 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • Table 56: Asia-Pacific Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 57: Asia-Pacific 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
REST OF WORLD
  • Table 58: Rest of World Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 59: Rest of World 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • Table 60: Rest of World Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 61: Rest of World 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aptar Digital Health
  • Better Therapeutics, Inc
  • Biofourmis Inc.
  • Canary Health, Inc.
  • Click Therapeutics, Inc.
  • Fitbit Health Solutions
  • Pear Therapeutics, Inc.
  • Wellthy Therapeutics Pvt Ltd

Table Information